Home > Boards > US Listed > Biotechs >

Biogen (BIIB)

BIIB RSS Feed
Add BIIB Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/12/2020 10:48:46 AM - Followers: 32 - Board type: Free - Posts Today: 0

 http://www.idecpharm.com/

http://finance.yahoo.com/q/ks?s=BIIB

Biogen Idec Inc., a biotechnology company, develops, manufactures, and commercializes novel therapeutics in the areas of neurology, oncology, immunology, cardiopulmonary, and hemophilia in the United States and internationally. The company?s marketed products include AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, low-grade or follicular, CD20-positive, and B-cell Non-Hodgkin?s Lymphoma (NHL); TYSABRI to treat relapsing MS; and FUMADERM for the treatment of severe psoriasis. Its products under development consist of BG-12, a Phase III clinical trial product for the treatment of MS; Humanized Anti-CD20 MAb, a Phase III clinical trial product for the treatment of rheumatoid arthritis and lupus nephritis; Lixivaptan, a Phase III clinical drug for the treatment of Hyponatremia; Daclizumab, a Phase II monoclonal antibody that is being tested in relapsing MS; and Fampridine, an oral compound as a treatment to improve walking ability in people with MS. The company?s products under preclinical stage comprise BIIB014, Ocrelizumab, Neublastin, LINGO, and BART for neurology; Hsp90 Inhibitor, GA101, Anti-IGF-1R, Volociximab, Anti-CRIPTO, RAF Inhibitor, and Anti-Fn14 for oncology; Anti-TWEAK, Anti-CD40L Fab, and Anti-FcRn for immunology; and Long-acting rFactor VIII for hemophilia. It has collaboration agreements with Neurimmune SubOne AG; Cardiokine Biopharma LLC; UCB, S.A.; Swedish Orphan Biovitrum AB; Facet Biotech Corporation; Vernalis plc; and Schering AG. The company was founded in 1985 and is based in Cambridge, Massachusetts.

BIIB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BIIB News: S&P 500 buybacks up 3.2% in Q4 2019; Full Year 2019 down 9.6% from record 2018, as companies brace for a more volatile 2020 03/24/2020 08:15:00 AM
BIIB News: Statement of Changes in Beneficial Ownership (4) 02/19/2020 06:21:46 PM
BIIB News: Statement of Changes in Beneficial Ownership (4) 02/19/2020 06:18:34 PM
BIIB News: Statement of Changes in Beneficial Ownership (4) 02/19/2020 06:14:38 PM
BIIB News: Statement of Changes in Beneficial Ownership (4) 02/19/2020 06:10:08 PM
PostSubject
#502   this post was not meant for Biogen..sorry..too late McMagyar 03/12/20 10:48:46 AM
#501   Even if they get approval on Frankie Docs gonna McMagyar 03/12/20 10:30:35 AM
#500   Repeat.. We are not looking for partners.. Not doing it.. McMagyar 03/12/20 10:29:22 AM
#499   What is the outlook for Promis as far noretreat 02/18/20 03:37:07 PM
#498   Promis might very well have a better anti-amyloid Doc328 02/16/20 12:27:48 PM
#497   “Buffett betting on aducanumab? Berkshire Hathaway takes a Phoenix300 02/14/20 10:05:07 PM
#496   Terrible news for the sick McMagyar 02/05/20 02:30:18 PM
#495   OK, what the heck is about to happen here? fung_derf 02/05/20 01:28:24 PM
#494   Is biogen looking at Promis Neurosciences PMN310? Similar Gbathat 01/02/20 06:21:39 PM
#493   Third shade of red is the charm says McMagyar 12/12/19 09:07:17 PM
#492   Aducamab is now a pig with lipstick mrplmer 12/12/19 12:58:05 PM
#491   Biogen's CTAD Presentation On Aducanumab Elicits Mixed Response jonny_red 12/05/19 04:52:02 PM
#490   Hahaha! JSmoove 12/04/19 10:12:37 PM
#489   But wait Biogen has the cure for Alzheimer’s! McMagyar 11/14/19 10:52:07 AM
#488   So you may be asking yourself if Biogen McMagyar 11/06/19 08:22:27 AM
#487   “Engage, is still a clear failure. At the McMagyar 10/26/19 09:51:21 PM
#486   That Phase I trial started with 165 participants, McMagyar 10/26/19 07:08:51 PM
#485   Anyone want to wager? Biogen raises some funds Before Dec? McMagyar 10/26/19 12:42:29 PM
#484   You let them do it to you again McMagyar 10/25/19 12:15:32 PM
#483   With a major breakthrough in mankind’s biggest disease McMagyar 10/25/19 09:28:12 AM
#482   Wonder why BIIB MICHAEL Ehlers stepped down from McMagyar 10/25/19 08:40:32 AM
#481   Don’t believe in betting against people tryin g McMagyar 10/25/19 08:36:01 AM
#480   Pradaxa does more in the Mouse model for McMagyar 10/25/19 08:33:18 AM
#479   Make your money before they publish this combed McMagyar 10/25/19 08:32:18 AM
#478   I am going all in on Biogen! Now it McMagyar 10/25/19 08:28:17 AM
#477   Last two times it took about a month McMagyar 10/24/19 03:31:07 PM
#476   "I would recommend selling shares in Biogen before Greenspam3 10/24/19 02:37:29 PM
#475   https://seekingalpha.com/article/4298721-biogen-amyloid-alzheimers-disease-rabbi Greenspam3 10/24/19 02:27:27 PM
#474   Look at Pradaxa animal testing. Anticoagulant is better chance McMagyar 10/23/19 11:46:41 PM
#473   Going to short the shit out of this Danorocket 10/23/19 08:39:31 PM
#472   Stealing money from ACTUAL drugs that may work McMagyar 10/23/19 05:23:23 PM
#471   Who is going to risk brain swelling for McMagyar 10/23/19 05:20:11 PM
#470   Madoff working it from his cell McMagyar 10/23/19 05:18:18 PM
#469   Biogen Reverses Take on Aducanumab Trial Data conix 10/23/19 02:44:23 PM
#468   BIIB orchestrates a $20 billion pumpndump Bourbon_on_my_cornflakes 10/23/19 11:44:07 AM
#467   biogen has so many sheisters to thank for McMagyar 10/22/19 06:16:48 PM
#466   caution, it inflames at higher doses. and inflammation fr1ends4ever 10/22/19 04:47:01 PM
#465   No--not short. Nor long. conix 10/22/19 03:00:10 PM
#464   Short on the news, not before. Bourbon_on_my_cornflakes 10/22/19 02:23:57 PM
#463   IMO most shorts had covered already after the semi_infinite 10/22/19 02:04:06 PM
#462   I, too, feel for all the shorters in BIIB. conix 10/22/19 01:44:27 PM
#461   The perfect heist by BIIB mgt. Bourbon_on_my_cornflakes 10/22/19 01:36:53 PM
#460   Halleluiah! fung_derf 10/22/19 10:51:15 AM
#459   Biogen Up 30% on Alzheimer’s drug revival: ‘It conix 10/22/19 10:40:39 AM
#458   BIIB stops both Elenbecestat and BAN2401 prematurely, stating fr1ends4ever 09/15/19 01:50:41 PM
#457   BIIB needs to look at this ALZ Rx. Biobillionair 05/25/19 07:02:30 PM
#456   Trend is down here from its 3yr high starkd748 05/24/19 08:00:51 AM
#455   Obviously there's a HUGE value for an AD treatment.... growacet 05/12/19 02:56:27 AM
#454   Added more this am.... Lazarus 05/10/19 11:11:08 AM
#453   US Citizens can now buy Biogens Avonex tw0122 04/28/19 09:15:09 AM
PostSubject